Get the Stockscreener App
3.24
3.85%
0.12
After Hours:
3.19
-0.05
-1.54%
Anavex Life Sciences Corporation Stock (AVXL) Forecast
The Anavex Life Sciences Corporation (AVXL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.31, representing a +341.73% increase from the current price of $3.24. The highest analyst price target is $17.03, and the lowest is $11.59.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AVXL Price Target
Average 21.40
(+560.57% Upside)
Is Anavex Life Sciences Corporation (AVXL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 42.97 | Neutral |
| STOCH(9,6) | 65.38 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.30 | Buy |
| ADX(14) | 24.55 | Neutral |
| William %R | -9.9237 | Sell |
| CCI(14) | 22.21 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.064
Buy
|
3.1405
Buy
|
| MA20 |
3.306
Sell
|
3.3506
Sell
|
| MA50 |
3.9398
Sell
|
3.8416
Sell
|
| MA100 |
4.0643
Sell
|
4.5791
Sell
|
| MA200 |
6.7259
Sell
|
5.8212
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, AVXL could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on AVXL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 42.97 indicates that AVXL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 65.38 indicates that AVXL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that AVXL is oversold. This suggests that AVXL price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.55 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 22.21 indicates that AVXL is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term AVXL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Anavex Life Sciences Corporation financial reports and earnings history, Anavex Life Sciences Corporation (AVXL) stock could reach $5.1516 by 2030, $10.69 by 2040 and $16.72 by 2050. See the projected annual prices until 2050 of the Anavex Life Sciences Corporation stock below:
- Anavex Life Sciences Corporation (AVXL) is expected to reach an average price of $8.4808 in 2035, with a high prediction of $8.9508 and a low estimate of $6.5976. This indicates an $161.75% rise from the last recorded price of $3.24.
- Anavex Life Sciences Corporation (AVXL) stock is projected to chart a bullish course in 2040, with an average price target of $10.22, representing an $215.30% surge from its current level. The forecast ranges from a conservative $9.5134 to a sky-high $10.69.
- Our analysts predict Anavex Life Sciences Corporation (AVXL) to jump 308.19% by 2045, soaring from $11.58 to an average price of $13.23, potentially reaching $13.87. While $11.58 is the low estimate, the potential upside is significant.
- Anavex Life Sciences Corporation (AVXL) stock is expected to climb by 2050, reaching an average of $16.43, a $407.07% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.72 and $13.22, respectively, highlighting the market's uncertainty.
Anavex Life Sciences Corporation Stock (AVXL) Year by Year Forecast
Anavex Life Sciences Corporation Stock (AVXL) Price Forecast for 2026
The predicted value for Anavex Life Sciences Corporation (AVXL) in 2026 is set at an average of $18.65. Estimates vary from a peak of $32.15 to a trough of $5.1519, indicating an +475.63% surge from the present price of $3.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2026 | $15.53 | $11.59 | $17.03 | +379.40% |
| June, 2026 | $15.23 | $13.44 | $16.80 | +370.18% |
| July, 2026 | $11.73 | $10.66 | $15.39 | +261.91% |
| August, 2026 | $16.15 | $11.46 | $16.64 | +398.38% |
| September, 2026 | $25.72 | $17.35 | $32.15 | +693.81% |
| October, 2026 | $20.00 | $18.02 | $27.51 | +517.30% |
| November, 2026 | $20.14 | $18.22 | $21.62 | +521.69% |
| December, 2026 | $18.60 | $17.20 | $21.30 | +474.22% |
Anavex Life Sciences Corporation Stock (AVXL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Anavex Life Sciences Corporation (AVXL) is $16.09, with a high forecast of $24.39 and a low forecast of $7.7993. This indicates an +396.71% increase from the last price of $3.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $18.51 | $17.35 | $19.10 | +471.18% |
| February, 2027 | $20.90 | $17.89 | $24.39 | +545.00% |
| March, 2027 | $18.80 | $16.91 | $21.96 | +480.24% |
| April, 2027 | $15.05 | $14.09 | $20.49 | +364.55% |
| May, 2027 | $11.09 | $10.59 | $14.89 | +242.38% |
| June, 2027 | $11.03 | $9.9442 | $13.94 | +240.59% |
| July, 2027 | $12.98 | $10.56 | $14.06 | +300.51% |
| August, 2027 | $10.30 | $10.28 | $13.67 | +217.84% |
| September, 2027 | $10.38 | $7.7993 | $10.50 | +220.37% |
| October, 2027 | $9.1417 | $8.0317 | $10.47 | +182.15% |
| November, 2027 | $13.45 | $9.3821 | $13.77 | +315.23% |
| December, 2027 | $12.33 | $10.32 | $14.06 | +280.41% |
Anavex Life Sciences Corporation Stock (AVXL) Price Forecast for 2028
In 2028, Anavex Life Sciences Corporation (AVXL) is projected to reach an average price of $12.03, with a high projection of $15.92 and a low estimate of $8.1311. This indicates an +271.18% rise from the last price of $3.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.8969 | $9.8669 | $12.65 | +205.46% |
| February, 2028 | $11.00 | $9.5485 | $11.34 | +239.46% |
| March, 2028 | $12.85 | $10.74 | $14.02 | +296.62% |
| April, 2028 | $12.57 | $11.65 | $15.92 | +288.03% |
| May, 2028 | $9.134 | $8.3132 | $13.91 | +181.91% |
| June, 2028 | $10.99 | $8.6944 | $12.02 | +239.06% |
| July, 2028 | $11.23 | $10.53 | $12.61 | +246.52% |
| August, 2028 | $9.6692 | $9.2242 | $11.41 | +198.43% |
| September, 2028 | $8.4807 | $8.3757 | $10.55 | +161.75% |
| October, 2028 | $9.1323 | $8.1311 | $9.3223 | +181.86% |
| November, 2028 | $9.8343 | $8.7127 | $10.42 | +203.53% |
| December, 2028 | $8.8259 | $8.5659 | $10.86 | +172.40% |
Anavex Life Sciences Corporation Stock (AVXL) Price Forecast for 2029
The 2029 price forecast for Anavex Life Sciences Corporation Stock (AVXL) is $7.5614 on average, with a high prediction of $11.16 and a low estimate of $3.9653. This represents an +133.38% increase from the previous price of $3.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.9479 | $8.3176 | $9.4367 | +176.17% |
| February, 2029 | $8.7395 | $8.2793 | $10.59 | +169.74% |
| March, 2029 | $8.2711 | $8.2511 | $9.091 | +155.28% |
| April, 2029 | $6.7526 | $6.5026 | $8.6214 | +108.41% |
| May, 2029 | $6.4446 | $5.6034 | $6.9746 | +98.91% |
| June, 2029 | $8.2762 | $6.175 | $8.3262 | +155.44% |
| July, 2029 | $10.02 | $8.2866 | $11.16 | +209.19% |
| August, 2029 | $6.6798 | $6.459 | $7.6582 | +106.17% |
| September, 2029 | $5.6314 | $5.5814 | $6.861 | +73.81% |
| October, 2029 | $5.3733 | $5.3433 | $6.2861 | +65.84% |
| November, 2029 | $4.4949 | $4.3149 | $5.9137 | +38.73% |
| December, 2029 | $4.29 | $3.9653 | $4.6253 | +32.41% |
Anavex Life Sciences Corporation Stock (AVXL) Price Forecast for 2030
Anavex Life Sciences Corporation Stock (AVXL) is expected to reach an average price of $5.4858 in 2030, with a high forecast of $7.5456 and a low forecast of $3.4261. This signifies an +69.32% surge from the last price of $3.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.244 | $4.0524 | $5.1516 | +30.99% |
| February, 2030 | $4.4371 | $4.1948 | $5.2963 | +36.95% |
| March, 2030 | $3.6353 | $3.5703 | $4.5179 | +12.20% |
| April, 2030 | $3.83 | $3.4261 | $4.1435 | +18.21% |
| May, 2030 | $4.3702 | $3.7843 | $4.8566 | +34.88% |
| June, 2030 | $3.9806 | $3.8598 | $4.5482 | +22.86% |
| July, 2030 | $3.5596 | $3.5238 | $4.183 | +9.86% |
| August, 2030 | $3.6477 | $3.4812 | $4.6762 | +12.58% |
| September, 2030 | $4.2209 | $3.5785 | $4.2909 | +30.27% |
| October, 2030 | $6.2249 | $3.9933 | $6.6149 | +92.13% |
| November, 2030 | $3.893 | $3.788 | $7.5456 | +20.16% |
| December, 2030 | $3.8412 | $3.4488 | $4.7004 | +18.56% |
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):